- Home
- GOSS vs PBPB Comparison
GOSS vs PBPB Comparison
Compare GOSS & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PBPB
- Stock Information
- Founded
- GOSS 2015
- PBPB 1977
- Country
- GOSS United States
- PBPB United States
- Employees
- GOSS N/A
- PBPB N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PBPB Restaurants
- Sector
- GOSS Health Care
- PBPB Consumer Discretionary
- Exchange
- GOSS Nasdaq
- PBPB Nasdaq
- Market Cap
- GOSS 212.9M
- PBPB 253.7M
- IPO Year
- GOSS 2019
- PBPB 2013
- Fundamental
- Price
- GOSS $0.74
- PBPB $10.11
- Analyst Decision
- GOSS Strong Buy
- PBPB Strong Buy
- Analyst Count
- GOSS 5
- PBPB 3
- Target Price
- GOSS $9.20
- PBPB $15.67
- AVG Volume (30 Days)
- GOSS 881.6K
- PBPB 182.8K
- Earning Date
- GOSS 11-07-2024
- PBPB 11-07-2024
- Dividend Yield
- GOSS N/A
- PBPB N/A
- EPS Growth
- GOSS N/A
- PBPB 641.95
- EPS
- GOSS N/A
- PBPB 1.25
- Revenue
- GOSS $105,322,000.00
- PBPB $471,719,000.00
- Revenue This Year
- GOSS N/A
- PBPB N/A
- Revenue Next Year
- GOSS N/A
- PBPB $3.41
- P/E Ratio
- GOSS N/A
- PBPB $8.09
- Revenue Growth
- GOSS N/A
- PBPB N/A
- 52 Week Low
- GOSS $0.50
- PBPB $6.28
- 52 Week High
- GOSS $1.60
- PBPB $14.36
- Technical
- Relative Strength Index (RSI)
- GOSS 22.63
- PBPB 68.02
- Support Level
- GOSS $0.78
- PBPB $10.01
- Resistance Level
- GOSS $0.92
- PBPB $10.94
- Average True Range (ATR)
- GOSS 0.05
- PBPB 0.46
- MACD
- GOSS -0.01
- PBPB 0.27
- Stochastic Oscillator
- GOSS 0.00
- PBPB 77.38
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.